Biomind Labs is a biotechnology company developing fast-acting and controlled-release pharmaceuticals for neurological and neuropsychiatric disorders. Its pipeline spans programs for treatment-resistant depression, Alzheimer's disease, Parkinson's disease, fibromyalgia, chronic pain, addiction, and obesity.